project id: TCGA-PRAD; case submitter id: TCGA-ZG-A9L2; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 9.9; age at index: 70; days to birth: -25573; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 25573; ajcc clinical m: M0; ajcc clinical t: T3a; ajcc pathologic n: N0; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1154.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1056; initial weight: 390.0; sample id: df8eaf3a-68cd-421f-8494-17b09866d457; sample submitter id: TCGA-ZG-A9L2-01A; percent necrosis: 0.0; section location: TOP;